Differentiation-inducing Therapeutic Effect of Notch Inhibition in Reversing Malignant Transformation of Liver Normal Stem Cells Via MET

Overview

Journal Oncotarget

Specialty Oncology

Date 2018 May 4

PMID 29721169

Citations 7

Authors

Hao Luo

Wei-hui Liu

Hong-Yin Liang

Hong-Tao Yan

Ning Lin

Dong-Yu Li

Tao Wang

Li-Jun Tang

Affiliations

Soon will be listed here.

Abstract

Background: Liver cancer stem cells (LCSCs) are the key factors for cancer metastasis, recurrent, and drug resistance. LCSCs are originated from either hepatocytes dedifferentiation or differentiation arresting of liver normal stem cells (LNSCs). Differentiation-inducing therapy is a novel strategy in solid tumors. Furthermore, Notch signaling pathway has been proved to play important role in the process of hepatocytes differentiation. In previous study, a malignant transformation cellular model of LNSCs has been built up, and in this study we are trying to illustrate whether inhibition of Notch can reverse this malignant tendency and drive these malignant cells back to differentiate into mature hepatocytes.

Results: Inhibition of Notch signaling pathway can down-regulate the stemness-related cancer markers, lower the proliferative status, alleviate the invasive characteristic, or attenuate the metastasis tendency. What is more, it can help the malignantly transformed cells to regain the mature hepatic function of glucagon synthesis, urea metabolism, albumin production, and indocyanine-green (ICG) clearance.

Materials And Methods: HOX transcript antisense RNA (HOTAIR) expression was enhanced in LNSCs via lentivirus transduction to set up the malignant transformation cellular model. Then, a Notch inhibitor was applied to induce malignantly transformed cells differentiate into mature hepatocytes, and malignant abilities of proliferation, invasiveness, tumorigenesis as well as mature hepatocyte function were observed and compared.

Conclusions: The data demonstrate that the anti-tumor effects of Notch inhibition may lie not only on killing the cancer cells or LCSCs directly, it can also induce the LCSCs differentiation into mature hepatocytes via mesenchymal-epithelial transition (MET) progress or downgrade the malignancy.

Citing Articles

Hepatocellular carcinoma: signaling pathways and therapeutic advances.

Zheng J, Wang S, Xia L, Sun Z, Chan K, Bernards R Signal Transduct Target Ther. 2025; 10(1):35.

PMID: 39915447 PMC: 11802921. DOI: 10.1038/s41392-024-02075-w.

Integrating single cell analysis and machine learning methods reveals stem cell-related gene S100A10 as an important target for prediction of liver cancer diagnosis and immunotherapy.

Huang S, Tu T Front Immunol. 2025; 15():1534723.

PMID: 39840058 PMC: 11747724. DOI: 10.3389/fimmu.2024.1534723.

Evaluation of different media compositions promoting hepatocyte differentiation in the canine liver organoid model.

Gabriel V, Lincoln A, Zdyrski C, Ralston A, Wickham H, Honold S Heliyon. 2024; 10(7):e28420.

PMID: 38590903 PMC: 10999936. DOI: 10.1016/j.heliyon.2024.e28420.

Drug Repurposing by Tumor Tissue Editing.

Luke F, Harrer D, Pantziarka P, Pukrop T, Ghibelli L, Gerner C Front Oncol. 2022; 12:900985.

PMID: 35814409 PMC: 9270020. DOI: 10.3389/fonc.2022.900985.

Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers.

Gramantieri L, Giovannini C, Suzzi F, Leoni I, Fornari F Cancers (Basel). 2021; 13(18).

PMID: 34572776 PMC: 8472624. DOI: 10.3390/cancers13184550.

References

Yimlamai D, Christodoulou C, Galli G, Yanger K, Pepe-Mooney B, Gurung B . Hippo pathway activity influences liver cell fate. Cell. 2014; 157(6):1324-1338. PMC: 4136468. DOI: 10.1016/j.cell.2014.03.060. View

Zhang Y, Song W, Zhang F, Liu W, Dou K . Differentiation-inducing activity of hydroxycamptothecin on cancer stem-like cells derived from hepatocellular carcinoma. Dig Dis Sci. 2011; 56(8):2473-81. DOI: 10.1007/s10620-011-1601-6. View

Lu J, Zhou Y, Hu T, Zhang H, Shen M, Cheng P . Notch Signaling Coordinates Progenitor Cell-Mediated Biliary Regeneration Following Partial Hepatectomy. Sci Rep. 2016; 6:22754. PMC: 4782135. DOI: 10.1038/srep22754. View

Wang T, Chen T, Liang H, Yan H, Lin N, Liu L . Notch inhibition promotes fetal liver stem/progenitor cells differentiation into hepatocytes via the inhibition of HNF-1β. Cell Tissue Res. 2014; 357(1):173-84. DOI: 10.1007/s00441-014-1825-9. View

Tofilon P, Vines C, Milas L . Enhancement of in vitro chemotherapeutic activity by dimethylsulfoxide. Clin Exp Metastasis. 1985; 3(2):141-50. DOI: 10.1007/BF01758962. View

Che L, Fan B, Pilo M, Xu Z, Liu Y, Cigliano A . Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans. Oncogenesis. 2016; 5(12):e274. PMC: 5177771. DOI: 10.1038/oncsis.2016.73. View

Wang T, You N, Tao K, Wang X, Zhao G, Xia N . Notch is the key factor in the process of fetal liver stem/progenitor cells differentiation into hepatocytes. Dev Growth Differ. 2012; 54(5):605-17. DOI: 10.1111/j.1440-169X.2012.01363.x. View

Wu J, Lu M, Li Y, Shang Y, Wang S, Meng Y . Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells. Oncogene. 2016; 35(42):5468-5479. DOI: 10.1038/onc.2016.89. View

Majlesara A, Golriz M, Hafezi M, Saffari A, Stenau E, Maier-Hein L . Indocyanine green fluorescence imaging in hepatobiliary surgery. Photodiagnosis Photodyn Ther. 2016; 17:208-215. DOI: 10.1016/j.pdpdt.2016.12.005. View

10.

Cigliano A, Wang J, Chen X, Calvisi D . Role of the Notch signaling in cholangiocarcinoma. Expert Opin Ther Targets. 2017; 21(5):471-483. DOI: 10.1080/14728222.2017.1310842. View

11.

Suzuki A, Sekiya S, Onishi M, Oshima N, Kiyonari H, Nakauchi H . Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. Hepatology. 2008; 48(6):1964-78. DOI: 10.1002/hep.22558. View

12.

Guest R, Boulter L, Dwyer B, Kendall T, Man T, Minnis-Lyons S . Notch3 drives development and progression of cholangiocarcinoma. Proc Natl Acad Sci U S A. 2016; 113(43):12250-12255. PMC: 5086988. DOI: 10.1073/pnas.1600067113. View

13.

Yamashita T, Honda M, Nio K, Nakamoto Y, Yamashita T, Takamura H . Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation. Cancer Res. 2010; 70(11):4687-97. DOI: 10.1158/0008-5472.CAN-09-4210. View

14.

Bi P, Yue F, Karki A, Castro B, Wirbisky S, Wang C . Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice. J Exp Med. 2016; 213(10):2019-37. PMC: 5030803. DOI: 10.1084/jem.20160157. View

15.

You K, Sun P, Yue Z, Li J, Xiong W, Wang J . NOR1 promotes hepatocellular carcinoma cell proliferation and migration through modulating the Notch signaling pathway. Exp Cell Res. 2017; 352(2):375-381. DOI: 10.1016/j.yexcr.2017.02.032. View

16.

Alizadeh E, Zarghami N, Baghaban Eslaminejad M, Akbarzadeh A, Barzegar A, Mohammadi S . The effect of dimethyl sulfoxide on hepatic differentiation of mesenchymal stem cells. Artif Cells Nanomed Biotechnol. 2014; 44(1):157-64. DOI: 10.3109/21691401.2014.928778. View

17.

Zeng C, Shang W, Wang K, Chi C, Jia X, Fang C . Intraoperative Identification of Liver Cancer Microfoci Using a Targeted Near-Infrared Fluorescent Probe for Imaging-Guided Surgery. Sci Rep. 2016; 6:21959. PMC: 4770417. DOI: 10.1038/srep21959. View

18.

Ning B, Ding J, Yin C, Zhong W, Wu K, Zeng X . Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res. 2010; 70(19):7640-51. DOI: 10.1158/0008-5472.CAN-10-0824. View

19.

You N, Liu W, Zhong X, Ji R, Zhang M, You H . Tg737 inhibition results in malignant transformation in fetal liver stem/progenitor cells by promoting cell-cycle progression and differentiation arrest. Mol Carcinog. 2011; 51(8):659-73. DOI: 10.1002/mc.20839. View

20.

Benzoubir N, Mussini C, Lejamtel C, Dos Santos A, Guillaume C, Desterke C . Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma. PLoS One. 2015; 10(6):e0130559. PMC: 4482489. DOI: 10.1371/journal.pone.0130559. View